Europa · Agencias y tiempo real · ANP

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

Publicado por ANP · Países Bajos hace 1 d

Late-breaking data presented at TCT 2026 and published simultaneously in JACC: Cardiovascular Interventions show durable benefit with MagicTouch PTA, with similar walking…

Leer el artículo completo en ANP Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (persportaal.anp.nl)

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

También te puede interesar

Consortium led by Boehly preparing securities swap deal for Lukoil assets — Reuters

Binance says hackers used fake job interviews in $6.34B crypto theft

Europe’s stock price problem and circling the US wagons

Europe-wide bomb threats disrupt air travel

Why are US linerboard prices rising faster than underlying costs?

Ferrari says Luce EV sold out for 2027, expects demand to grow further

SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopli

Compartir

También te puede interesar

Consortium led by Boehly preparing securities swap deal for Lukoil assets — Reuters

Binance says hackers used fake job interviews in $6.34B crypto theft

Europe’s stock price problem and circling the US wagons

Europe-wide bomb threats disrupt air travel

Why are US linerboard prices rising faster than underlying costs?

Ferrari says Luce EV sold out for 2027, expects demand to grow further